Does Dr. BRUCE BLAZAR have financial conflicts of interest?

Dr. BRUCE BLAZAR (M.D.) has received a total of $1,077,650 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,075,150 in personal promotional payouts (consulting, meals, travel) and $2,500 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. BRUCE BLAZAR?

According to CMS Open Payments data, Dr. BRUCE BLAZAR received funding from BAYER HEALTHCARE PHARMACEUTICALS ($634,976), BLUEROCK THERAPEUTICS ($415,947), and MODERNATX ($7,500).

Does Dr. BRUCE BLAZAR receive research grants or speaking fees?

Dr. BRUCE BLAZAR has received $1,075,150 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $2,500 in clinical research grants.

DR. BRUCE BLAZAR

M.D.Real-Time Hydrated

Specialty: Pediatrics, Pediatric Hematology-Oncology

Practice Location: MINNEAPOLIS, MN 55455

NPI Number: 1003842162

LIFETIME INDUSTRY VALUE

$1,077,650

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BLAZAR is a verified Pediatrics, Pediatric Hematology-Oncology practitioner based in MINNEAPOLIS, MN.

Between 2021 and 2025, Dr. BLAZAR had an overall industry promotional and research financial footprint of $1,077,650 as recorded in the federal CMS Open Payments database.

$1,075,150 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$2,500 was allocated to sponsored clinical trials and medical research activities.

Dr. BLAZAR's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $634,976 (representing 58.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$634,976

58.9%

BLUEROCK THERAPEUTICS

Rank 2

$415,947

38.6%

MODERNATX

Rank 3

$7,500

0.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.